US Drug Recall Register

Is Histamine recalled?

Yes — there is an active recall. 4 ongoing FDA recalls mention Histamine (109 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Histamine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed.

Class II · Moderate risk Terminated

Fexofenadine Hydrochloride Tablets

Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Cardinal Health Inc. NDC 45802-571-78 D-0546-2021
Class III · Low risk Terminated

Discount Drug Mart

Reason Labeling: Incorrect or Missing Lot and/or Expiration date.

AAA Pharmaceutical, Inc. NDC 53943-192-04 D-0868-2020
Class II · Moderate risk Terminated

CVS Health Children's Allergy Relief Liquid Medication…

Reason CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.

Unipharma, Llc. NDC 69842-261-01 D-1631-2019
Class II · Moderate risk Terminated

AbeeMed cream

Reason CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Pharma-Natural Inc. D-1493-2019
Class II · Moderate risk Terminated

Cetirizine Oral Solution 1 mg/mL

Reason cGMP Deviations: Firm was notified by their supplier of Cetirizine HCL Oral Solution, USP, 1mg/mL, 4oz, of the voluntary recall that they have initiated due to potential contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

P & L Developments, LLC NDC 11673-178-04 D-1409-2019
Class II · Moderate risk Terminated

Cetirizine Oral Solution 1 mg/mL

Reason cGMP Deviations: Firm was notified by their supplier of Cetirizine HCL Oral Solution, USP, 1mg/mL, 4oz, of the voluntary recall that they have initiated due to potential contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

P & L Developments, LLC NDC 63868-430-04 D-1408-2019
Class II · Moderate risk Terminated

Cetirizine HCL Oral Solution 1 mg/mL

Reason cGMP Deviations: Firm was notified by their supplier of Cetirizine HCL Oral Solution, USP, 1mg/mL, 4oz, of the voluntary recall that they have initiated due to potential contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

P & L Developments, LLC NDC 55910-878-04 D-1407-2019
Class II · Moderate risk Terminated

Kid Kare Childrens Cough/Cold Liquid

Reason cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Torrent Pharma Inc D-1367-2019
Class II · Moderate risk Terminated

Pedia Relief Cough-Cold Oral Solution

Reason cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Torrent Pharma Inc D-1356-2019
Class II · Moderate risk Terminated

Allergy Liquid Antihistamine

Reason cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Torrent Pharma Inc D-1347-2019
Class II · Moderate risk Terminated

CVS Health Children's Allergy Relief Liquid Medication…

Reason CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.

Unipharma, Llc. NDC 69842-261-01 D-1300-2019
Class II · Moderate risk Terminated

children's allergy

Reason Failed Impurities/Degradation Specifications: unknown impurity higher than the specified limit was detected during routine stability testing.

Taro Pharmaceuticals U.S.A., Inc. NDC 56062-106-08 D-0277-2019
Class III · Low risk Terminated

Allergy Relief Diphenhydramine HCl 25 mg

Reason Subpotent: This product is being recalled due to low out of specification assay results at the 9 month time point.

P & L Development, LLC NDC 36800-483-24 D-0694-2017
Class I · High risk Terminated

Mucinex Fast Max Night Time Cold & Flu

Reason Labeling: Label Mix-Up; Bottles of Mucinex Fast-Max liquid are correctly labeled on the front of the label, however the back of the bottle where the Drug Facts labeling is, is missing certain Active Ingredients such as acetaminophen, phenylephrine, dextromethorphan, diphenhydramine, and/or guaifenesin. As a result certain safety warnings associated with those ingredients may also be missing.

Reckitt Benckiser LLC NDC 63824-500-66 D-1364-2015
Class III · Low risk Terminated

Fexofenadine Hydrochloride Tablets

Reason Failed Impurities/Degradation Specifications: the manufacturer, recalled product due to slightly above specification results for a Related Compound during routine stability testing

Mylan Institutional, Inc. (d.b.a. UDL Laboratories) NDC 51079-547-20 D-1083-2015
Class III · Low risk Terminated

Fexofenadine HCl Tablets

Reason Failed Impurities/Degradation Specifications: out of specification results for a related compound - a degradant of fexofenadine.

Mylan Pharmaceuticals Inc. NDC 0378-0781-91 D-0435-2015
Class II · Moderate risk Terminated

Children's Loratadine Syrup

Reason Presence of Foreign Substance: Presence of blue plastic floating in loratadine syrup.

Taro Pharmaceuticals U.S.A., Inc. D-0383-2015
Class II · Moderate risk Terminated

Histamine Phosphate active pharmaceutical ingredient packaged in…

Reason Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Attix Pharmaceuticals D-706-2015
Class II · Moderate risk Terminated

Histamine Diphosphate active pharmaceutical ingredient packaged…

Reason Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Attix Pharmaceuticals D-705-2015